000			02001 a2200517 4500
005			20250514072723.0
264		0	_c20030808
008			200308s 0 0 eng d
022			_a1081-1206
024	7		_a10.1016/S1081-1206(10)61867-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aKaliner, Michael A
245	0	0	_aRelative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. _h[electronic resource]
260			_bAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _cJun 2003
300			_a629-34 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aCross-Over Studies
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Evaluation
650	0	4	_aFemale
650	0	4	_aHistamine H1 Antagonists _xadministration & dosage
650	0	4	_aHistamine Release _xdrug effects
650	0	4	_aHumans
650	0	4	_aLoratadine _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aReference Values
650	0	4	_aSkin Tests
650	0	4	_aTerfenadine _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aWhite, Martha V
700	1		_aEconomides, Athena
700	1		_aCrisalida, Tera
700	1		_aHale, Mary
700	1		_aLiao, Yuning
700	1		_aChristian, Claire D
700	1		_aGeorges, George C
700	1		_aWoodworth, Thomas H
700	1		_aMeeves, Suzanne G
773	0		_tAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _gvol. 90 _gno. 6 _gp. 629-34
856	4	0	_uhttps://doi.org/10.1016/S1081-1206(10)61867-4 _zAvailable from publisher's website
999			_c12621666 _d12621666